PL2468274T3 - Przezskórny układ terapeutyczny do podawania substancji czynnej - Google Patents
Przezskórny układ terapeutyczny do podawania substancji czynnejInfo
- Publication number
- PL2468274T3 PL2468274T3 PL10194968T PL10194968T PL2468274T3 PL 2468274 T3 PL2468274 T3 PL 2468274T3 PL 10194968 T PL10194968 T PL 10194968T PL 10194968 T PL10194968 T PL 10194968T PL 2468274 T3 PL2468274 T3 PL 2468274T3
- Authority
- PL
- Poland
- Prior art keywords
- agent
- application
- therapeutic system
- transdermal therapeutic
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10194968.3A EP2468274B1 (de) | 2010-12-14 | 2010-12-14 | Transdermales therapeutisches System zur Verabreichung eines Wirkstoffs |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2468274T3 true PL2468274T3 (pl) | 2015-11-30 |
Family
ID=43836835
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10194968T PL2468274T3 (pl) | 2010-12-14 | 2010-12-14 | Przezskórny układ terapeutyczny do podawania substancji czynnej |
PL11799413T PL2651410T3 (pl) | 2010-12-14 | 2011-12-14 | Transdermalny system terapeutyczny do podawania substancji czynnej |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11799413T PL2651410T3 (pl) | 2010-12-14 | 2011-12-14 | Transdermalny system terapeutyczny do podawania substancji czynnej |
Country Status (25)
Country | Link |
---|---|
US (2) | US10660863B2 (pl) |
EP (2) | EP2468274B1 (pl) |
JP (1) | JP6043296B2 (pl) |
KR (1) | KR101842309B1 (pl) |
CN (3) | CN113244199A (pl) |
AU (2) | AU2011343363B2 (pl) |
BR (1) | BR112013014616B1 (pl) |
CA (2) | CA3065240C (pl) |
CY (2) | CY1116638T1 (pl) |
DK (2) | DK2468274T3 (pl) |
EA (1) | EA026520B1 (pl) |
ES (2) | ES2545094T3 (pl) |
HK (1) | HK1243336A1 (pl) |
HR (2) | HRP20150881T1 (pl) |
HU (2) | HUE027916T2 (pl) |
LT (1) | LT2651410T (pl) |
MX (1) | MX345344B (pl) |
MY (1) | MY183873A (pl) |
PL (2) | PL2468274T3 (pl) |
PT (2) | PT2468274E (pl) |
RS (2) | RS54173B1 (pl) |
SI (2) | SI2468274T1 (pl) |
SM (1) | SMT201500184B (pl) |
WO (1) | WO2012080365A1 (pl) |
ZA (1) | ZA201303965B (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012000369A1 (de) * | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
DE102012016317A1 (de) | 2012-08-14 | 2014-02-20 | Jenabatteries GmbH | Redox-Flow-Zelle zur Speicherung elektrischer Energie |
EP2884969A1 (en) * | 2012-08-15 | 2015-06-24 | Dow Corning Corporation | Multi - layer transdermal drug delivery system |
WO2014111790A2 (en) * | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
JP6864968B2 (ja) | 2016-08-22 | 2021-04-28 | 救急薬品工業株式会社 | 貼付剤 |
EP3656383A4 (en) * | 2017-07-19 | 2021-05-19 | Teikoku Seiyaku Co., Ltd. | RIVASTIGMIN-CONTAINING PERCUTICAL ABSORPTION PREPARATION |
DE102018120506A1 (de) * | 2017-10-20 | 2019-04-25 | Amw Gmbh | Stabilisiertes transdermales Darreichungssystem |
DE102017127433A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
US20210038532A1 (en) * | 2018-03-13 | 2021-02-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
JP7170285B2 (ja) * | 2018-05-17 | 2022-11-14 | パナソニックIpマネジメント株式会社 | 生体貼付け用選択透過膜、経皮吸収キットおよび美容方法 |
DK3513965T3 (da) | 2018-08-08 | 2022-07-25 | Danapak Flexibles As | Forbedrede film og laminater til anvendelse i pakning af reaktive forbindelser |
KR20200025883A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
KR20200025888A (ko) | 2018-08-31 | 2020-03-10 | 에스케이케미칼 주식회사 | 장기 투여용 리바스티그민 패취 |
WO2021005118A1 (en) * | 2019-07-09 | 2021-01-14 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive |
CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU201906B (en) | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
WO1994004109A1 (en) * | 1992-08-25 | 1994-03-03 | Cygnus Therapeutic Systems | Printed transdermal drug delivery device |
JPH0912448A (ja) * | 1995-04-28 | 1997-01-14 | Read Chem Kk | 薬物放出制御型経皮吸収製剤 |
GB9800526D0 (en) * | 1998-01-12 | 1998-03-11 | Ciba Geigy Ag | Organic compounds |
US6348210B1 (en) * | 1998-11-13 | 2002-02-19 | Alza Corporation | Methods for transdermal drug administration |
DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
DE10103860B4 (de) * | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US8252319B2 (en) * | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
ES2346895T3 (es) * | 2004-10-21 | 2010-10-21 | Durect Corporation | Sistemas de administracion transdermica. |
TWI389709B (zh) | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
JP2009521964A (ja) * | 2005-12-30 | 2009-06-11 | コロプラスト アクティーゼルスカブ | 皮膚接触表面としての成型可能な層を有する層状接着剤構成物 |
CN101304735A (zh) * | 2006-01-12 | 2008-11-12 | Lts勒曼治疗系统股份公司 | 用于挥发性和/或热不稳定的物质的经皮治疗体系 |
KR20090009951A (ko) | 2006-05-08 | 2009-01-23 | 데이고꾸세이약꾸가부시끼가이샤 | 항치매제를 포함하는 경피 흡수 제제 |
US9248104B2 (en) | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
EP2167001A4 (en) | 2007-07-10 | 2012-10-31 | Agile Therapeutics Inc | THERMAL DELIVERY DEVICE WITH ULTRASONIC WELDING |
WO2009026135A2 (en) | 2007-08-17 | 2009-02-26 | Alza Corporation | Controlled transdermal bisoprolol delivery system |
EP2255802B1 (en) * | 2008-02-27 | 2018-01-17 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch and packaged product |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
JP2010126450A (ja) * | 2008-11-25 | 2010-06-10 | Lintec Corp | 経皮吸収貼付剤 |
KR101674240B1 (ko) * | 2009-12-22 | 2016-11-08 | 아시노 아게 | 리바스티그민 또는 그의 유도체 투여용 경피 치료 시스템 |
-
2010
- 2010-12-14 PT PT101949683T patent/PT2468274E/pt unknown
- 2010-12-14 HU HUE10194968A patent/HUE027916T2/en unknown
- 2010-12-14 PL PL10194968T patent/PL2468274T3/pl unknown
- 2010-12-14 DK DK10194968.3T patent/DK2468274T3/en active
- 2010-12-14 SI SI201031006T patent/SI2468274T1/sl unknown
- 2010-12-14 RS RS20150562A patent/RS54173B1/en unknown
- 2010-12-14 EP EP10194968.3A patent/EP2468274B1/de active Active
- 2010-12-14 ES ES10194968.3T patent/ES2545094T3/es active Active
-
2011
- 2011-12-14 AU AU2011343363A patent/AU2011343363B2/en active Active
- 2011-12-14 PT PT117994137T patent/PT2651410T/pt unknown
- 2011-12-14 CN CN202110438860.3A patent/CN113244199A/zh active Pending
- 2011-12-14 MX MX2013005581A patent/MX345344B/es active IP Right Grant
- 2011-12-14 SI SI201131933T patent/SI2651410T1/sl unknown
- 2011-12-14 EP EP11799413.7A patent/EP2651410B1/de active Active
- 2011-12-14 CN CN201710451001.1A patent/CN107412202A/zh active Pending
- 2011-12-14 HU HUE11799413A patent/HUE052137T2/hu unknown
- 2011-12-14 CA CA3065240A patent/CA3065240C/en active Active
- 2011-12-14 BR BR112013014616-8A patent/BR112013014616B1/pt active IP Right Grant
- 2011-12-14 RS RS20201478A patent/RS61155B1/sr unknown
- 2011-12-14 CA CA2817461A patent/CA2817461C/en active Active
- 2011-12-14 DK DK11799413.7T patent/DK2651410T3/da active
- 2011-12-14 ES ES11799413T patent/ES2836483T3/es active Active
- 2011-12-14 WO PCT/EP2011/072812 patent/WO2012080365A1/de active Application Filing
- 2011-12-14 LT LTEP11799413.7T patent/LT2651410T/lt unknown
- 2011-12-14 PL PL11799413T patent/PL2651410T3/pl unknown
- 2011-12-14 US US13/994,242 patent/US10660863B2/en active Active
- 2011-12-14 KR KR1020137016047A patent/KR101842309B1/ko active IP Right Grant
- 2011-12-14 MY MYPI2013001975A patent/MY183873A/en unknown
- 2011-12-14 CN CN201180059614.1A patent/CN103269698B/zh active Active
- 2011-12-14 JP JP2013543774A patent/JP6043296B2/ja active Active
- 2011-12-14 EA EA201300704A patent/EA026520B1/ru not_active IP Right Cessation
-
2013
- 2013-05-30 ZA ZA2013/03965A patent/ZA201303965B/en unknown
-
2015
- 2015-07-31 SM SM201500184T patent/SMT201500184B/xx unknown
- 2015-08-19 HR HRP20150881TT patent/HRP20150881T1/hr unknown
- 2015-08-25 CY CY20151100738T patent/CY1116638T1/el unknown
-
2017
- 2017-08-11 AU AU2017213569A patent/AU2017213569B2/en active Active
-
2018
- 2018-02-28 HK HK18102858.7A patent/HK1243336A1/zh unknown
-
2020
- 2020-04-28 US US16/860,210 patent/US20200289426A1/en not_active Abandoned
- 2020-11-25 CY CY20201101121T patent/CY1123712T1/el unknown
- 2020-11-26 HR HRP20201880TT patent/HRP20201880T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1243336A1 (zh) | 用於施用活性物質的經皮治療系統 | |
HRP20181615T1 (hr) | Terapijsko sredstvo koje izaziva citotoksičnost | |
HUS2000018I1 (hu) | Mellékvese hormon-módosító szer alkalmazása | |
EP2523630A4 (en) | SYSTEMS AND METHODS FOR BARIATRIC THERAPY | |
IL250409B (en) | A system and method for the microbilization of embroidery | |
EP2770984A4 (en) | DEVICE AND METHOD FOR PROLONGED RELEASE OF THERAPEUTIC AGENT | |
IL224381B (en) | Application of b-functionalized dihydroxy-chlorins for pdt | |
ZA201301458B (en) | Therapeutic agent for pain | |
EP2485719A4 (en) | TRANSDERMAL THERAPEUTIC SYSTEM | |
PT2456445E (pt) | Agente para o tratamento de condições da pele | |
GB201010638D0 (en) | Composition for treatment of skin | |
GB201019938D0 (en) | Determination of therapeutic agents | |
GB201009614D0 (en) | Therapeutic use of compounds | |
GB201003727D0 (en) | Therapeutic agent | |
TWM402101U (en) | Structure of body-scraping therapeutic treatment device | |
PL393033A1 (pl) | Urządzenie do strumieniowo-jonowej, monitorowanej terapii ciała |